Exploring the Use of Antibiotics for Dental Patients in a Middle-Income Country: Interviews with Clinicians in Two Ghanaian Hospitals
Abstract
:1. Introduction
2. Method
2.1. Study Setting
2.2. Participants
- Dental and nursing staff who prescribe antibiotics for people with dental conditions in outpatient departments;
- Staff who prescribe antibiotics for dental inpatients;
- Pharmacy staff who dispense antibiotics and review prescriptions for antibiotics in dental patients.
2.3. Data Collection
2.4. Data Analysis
2.5. Ethics Approval
3. Results
3.1. Behavioural Specification
3.2. Key Themes and Subthemes
4. People and Places
4.1. Prescriber and Clinical Context
4.1.1. Prescribing Practices
Therapeutic Use for Treating Active Infections
Prophylactic Use to Prevent Infections
4.1.2. Resource Constraints
Access to Antibiotics—Availability and Affordability
Diagnostic Testing
Infection Prevention and Control
4.1.3. Influence of colleagues—Hierarchies
4.2. Pharmacists/Dispensers
Availability of Antibiotics without a Prescription
4.3. Patients
4.3.1. Delays in Seeking Professional Help
4.3.2. Hygiene Concerns
4.3.3. Medication Adherence
5. Knowledge and Training about AMR and AMS
5.1. Consequences of AMR
5.2. Causes of AMR
5.3. Role of Prescribers in Tackling AMR
6. Discussion
7. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. The Review on Antimicrobial Resistance. 2016. Available online: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed on 25 July 2022).
- Jonas, O.B.; Irwin, A.B.; Le Gall, F.C.J.; Francois, G.; Marquez, P.V. Drug-Resistant Infections: A Threat to Our Economic Future; Final Report (English); HNP/Agriculture Global Antimicrobial Resistance Initiative; World Bank Group: Washington, DC, USA, 2017; Volume 2, Available online: http://documents.worldbank.org/curated/en/323311493396993758/final-report (accessed on 25 July 2022).
- World Health Organization. Global Action Plan on AMR; WHO: Geneva, Switzerland, 2015. [Google Scholar]
- Thompson, W.; McEachan, R.; Pavitt, S.; Douglas, G.; Bowman, M.; Boards, J.; Sandoe, J. Clinician and Patient Factors Influencing Treatment Decisions: Ethnographic Study of Antibiotic Prescribing and Operative Procedures in Out-of-Hours and General Dental Practices. Antibiotics 2020, 9, 575. [Google Scholar] [CrossRef] [PubMed]
- FDI World Dental Federation. Policy Statements (2019)-Antibiotic Stewardship in Dentistry. Available online: https://www.fdiworlddental.org/antibiotic-stewardship-dentistry (accessed on 25 July 2022).
- Thompson, W.; Teoh, L.; Hubbard, C.C.; Marra, F.; Patrick, D.M.; Mamun, A.; Campbell, A.; Suda, K.J. Patterns of dental antibiotic prescribing in 2017: Australia, England, United States, and British Columbia (Canada). Infect. Control. Hosp. Epidemiol. 2021, 43, 191–198. [Google Scholar] [CrossRef] [PubMed]
- Thompson, W.; Tonkin-Crine, S.; Pavitt, S.H.; McEachan, R.R.C.; Douglas, G.V.A.; Aggarwal, V.R.; Sandoe, J.A.T. Factors associated with antibiotic prescribing for adults with acute conditions: An umbrella review across primary care and a systematic review focusing on primary dental care. J. Anti-Microb. Chemother. 2019, 74, 2139–2152. [Google Scholar] [CrossRef] [Green Version]
- Emmott, R.; Barber, S.K.; Thompson, W. Antibiotics and toothache: A social media review. Int. J. Pharm. Pr. 2021, 29, 210–217. [Google Scholar] [CrossRef] [PubMed]
- Agnihotry, A.; Thompson, W.; Fedorowicz, Z.; van Zuuren, E.J.; Sprakel, J. Antibiotic use for irreversible pulpitis. Cochrane Database Syst. Rev. 2019, 5, CD004969. [Google Scholar] [CrossRef] [PubMed]
- Cope, A.L.; Francis, N.A.; Wood, F.; Chestnutt, I.G. Antibiotic prescribing in UK general dental practice: A cross-sectional study. Community Dent. Oral Epidemiol. 2016, 44, 145–153. [Google Scholar] [CrossRef] [PubMed]
- Loeffler, C.; Boehmer, F. The effect of interventions aiming to optimise the prescription of antibiotics in dental care—A systematic review. PLoS ONE 2017, 12, e0188061. [Google Scholar] [CrossRef] [Green Version]
- Sneddon, J.; Afriyie, D.; Sefah, I.; Cockburn, A.; Kerr, F.; Byrne-Davis, L.; Cameron, E. Developing a Sustainable AMS (AMS) Programme in Ghana: Replicating the Scottish Triad Model of Information Education Quality, Improvement. Antibiotics 2020, 9, 636. [Google Scholar] [CrossRef] [PubMed]
- Darkwah, T.O.; Afriyie, D.K.; Sneddon, J.; Cockburn, A.; Opare-Addo, M.N.A.; Tagoe, B.; Amponsah, S.K. Assessment of prescribing patterns of antibiotics using National Treatment Guidelines and World Health Organization prescribing indicators at the Ghana Police Hospital: A pilot study. Pan Afr. Med. J. 2021, 39, 222. [Google Scholar] [CrossRef]
- Sefah, I.A.; Sneddon, J.; Essah, D.O.; Kurdi, A.; Fadare, J.; Jairoun, A.A.; Godman, B. Evaluation of antibiotic prescribing for ambulatory patients seeking primary dental care services in a public hospital in Ghana: A clinical audit study. JAC-Antimicrob. Resist. 2022, 4, 079. [Google Scholar] [CrossRef]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 2008, 3, 77–101. [Google Scholar] [CrossRef] [Green Version]
- Boije, H. Analysis in qualitative research. In Analysis in Qualitative Research; SAGE Publications: Thousand Oaks, CA, USA, 2010; pp. 19–42. [Google Scholar]
- Presseau, J.; McClear, N.; Lorencatto, F.; Patey, A.M.; Grimshaw, J.M.; Francis, J.J. Action, actor, context, target, time (AACTT): A framework for specifying be-haviour. Implement. Sci. 2019, 14, 102. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, S. The Socio-cultural Dynamics of Antibiotic Misuse in Hyderabad City, India: A Qualitative Study of Dentist and Pharmacist. J. Karnali Acad. Health Sci. 2019, 2, 197–202. [Google Scholar] [CrossRef] [Green Version]
- Alsan, M.; Schoemaker, L.; Eggleston, K.; Kammili, N.; Kolli, P.; Bhattacharya, J. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: An economic analysis. Lancet Infect. Dis. 2015, 15, 1203–1210. [Google Scholar] [CrossRef] [Green Version]
- Vardhan, T.H.; Lakhshmi, N.V.; Haritha, B. Exploring the pattern of antibiotic prescription by dentists: A questionnaire-based study. J. NTR. Univ. Health Sci. 2017, 6, 149–153. [Google Scholar] [CrossRef]
- NICE Guideline [NG15]. Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use. 2015. Available online: https://www.nice.org.uk/guidance/ng15 (accessed on 25 July 2022).
- Preus, H.R.; Fredriksen, K.W.; Vogsland, A.E.; Sandvik, L.; Grytten, J.I. Antibiotic-prescribing habits among Norwegian dentists: A survey over 25 years (1990–2015). Eur. J. Oral. Sci. 2017, 125, 280–287. [Google Scholar] [CrossRef]
- Vessal, G.; Khabiri, A.; Mirkhani, H.; Cookson, B.D.; Askarian, M. Study of antibiotic prescribing among dental practitioners in Shiraz, Islamic Republic of Iran. East. Mediterr. Health J. 2011, 17, 763–769. [Google Scholar] [CrossRef] [PubMed]
- Al-Haroni, M.; Nils Skaug, N. Knowledge of prescribing antimicrobials among Yemeni general dentists. Acta. Odontol. Scand. 2006, 64, 274–280. [Google Scholar] [CrossRef]
- Salako, N.O.; Rotimi, V.O.; Adib, S.M.; Al-Mutawa, S. Pattern of antibiotic prescription in the management of oral diseases among den-tists in Kuwait. J. Dent. 2004, 32, 503–509. [Google Scholar] [CrossRef]
- World Health Organization. Essential Medicines List Antibiotics Book; WHO: Geneva, Switzerland, 2022. [Google Scholar]
- Thompson, W.; Williams, D.; Pulcini, C.; Sanderson, S.; Calfon, P.; Verma, M. The Essential Role of the Dental Team in Reducing Antibiotic Resistance; FDI World Dental Federation: Geneva, Switzerland, 2020. [Google Scholar]
- Fadare, J.O.; Oshikoya, K.A.; Obimakinde, O.S.; Sijuade, A.O.; Afolayan, J.M.; Adeleke, A.A.; Godman, B.; Ojumu, D.O. Patterns of drugs prescribed for dental outpatients in Nigeria: Findings and implications. Acta. Odontol. Scand. 2017, 75, 496–506. [Google Scholar] [CrossRef] [Green Version]
- Sanz, M.; Herrera, D.; Kebschull, M.; Chapple, I.; Jepsen, S.; Beglundh, T.; Sculean, A.; Tonetti, M.S. On behalf of the EFP Workshop Participants and Methodological Consultants. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline. J. Clin. Periodontol. 2020, 47, 4–60. [Google Scholar] [CrossRef]
- Llewelyn, M.J.; Fitzpatrick, J.M.; Darwin, E.; SarahTonkin-Crine; Gorton, C.; Paul, J.; Peto, T.E.A.; Yardley, L.; Hopkins, S.; Walker, A.S. The antibiotic course has had its day. BMJ 2017, 358, j3418. [Google Scholar] [CrossRef] [Green Version]
- Palmer, N. (Ed.) Antimicrobial Prescribing in Dentistry: Good Practice Guidelines, 3rd ed.; Faculty of General Dental Practice (UK) and Faculty of Dental Surgery: London, UK, 2020. [Google Scholar]
- Bhuvaraghan, A.; King, R.; Larvin, H.; Aggarwal, V.R. Antibiotic Use and Misuse in Dentistry in India—A Systematic Review. Antibiotics 2021, 10, 1459. [Google Scholar] [CrossRef] [PubMed]
- Skivington, K.; Matthews, L.; Simpson, S.A.; Craig, P.; Baird, J.; Blazeby, J.M.; Boyd, K.A.; Craig, N.; French, D.P.; McIntosh, E.; et al. A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. BMJ 2021, 374, n2061. [Google Scholar] [CrossRef]
- Michie, S.; van Stralen, M.M.; West, R. The behaviour change wheel: A new method for characterising and designing behav-iour change interventions. Implement. Sci. 2011, 6, 42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Feder, G.; Eccles, M.; Grol, R.; Griffiths, C.; Grimshaw, J. Using clinical guidelines. BMJ 1999, 318, 728–730. [Google Scholar] [CrossRef] [PubMed]
- Venant, E.; Stanley, B.K.; Mosha, M.J.; Msovela, K.E.; Mushi, D.J.; Masanja, P.; Wiedenmayer, K.; Ombaka, E. P23 Assessment of knowledge, attitude and practice towards antimicrobial use and resistance among students in three secondary schools in Dodoma City. JAC-Antimicrob. Resist. 2022, 4 (Suppl. 1), dlac004.022. [Google Scholar] [CrossRef]
- Charoenboon, N.; Haenssgen, M.J.; Warapikuptanun, P.; Xayavong, T.; Zaw, Y.K. Translating antimicrobial resistance: A case study of context and consequences of antibiotic-related communication in three northern Thai villages. Palgrave Commun. 2019, 5, 23. [Google Scholar] [CrossRef] [Green Version]
- Conner, M.; Norman, P. Predicting Health Behaviour: Research and Practice with Social Cognition Models; Open University Press: Maidenhead, UK, 2005. [Google Scholar]
AACTT Framework | Dentistry Multi-Disciplinary Team | |
---|---|---|
Actor | Prescribers (Dentists, Dental surgery assistants, Physician assistants) | Dispensers (Pharmacists, Pharmacy technicians) |
Action | Prescribe antibiotics to patients | Dispense antibiotic prescriptions to patients |
Context | Dental clinics | Pharmacies |
Target | Prudent and appropriate prescription of antibiotics | No prescribing target in hospital setting but role is to ensure good practice in dispensing antibiotic prescriptions |
Time | When a patient attends the dental clinic to be treated for a dental condition | When a patient attends the pharmacy for antibiotics either via prescription or not |
Key Theme | Subthemes | ||
---|---|---|---|
1. People and places | Prescriber and clinical context | Prescribing practices | Therapeutic use |
Prophylactic use | |||
Resource constraints | Access to antibiotics | ||
Diagnostic tests | |||
Infection prevention and control | |||
Influence of colleagues | Hierarchies | ||
Dispenser and pharmacies | Availability of antibiotics in the community | ||
Patient and home environment | Delays in seeking professional help | ||
Hygiene concerns | |||
Medication adherence | |||
2. Knowledge and beliefs about AMR and ABS | Consequences of AMR | ||
Reasons for AMR | |||
Role of prescribers in tackling AMR |
Theme or Subtheme | Quote and Participant Number |
---|---|
1.1 Prescribing practices | ‘P drug is the list of drugs that you have become comfortable giving. So this P drug, everybody has their own way of going about it. So probably drugs that your bosses have used before which they found to be very effective might become drugs that can form part of your P drugs’. P4 |
1.1.1 Therapeutic use for treating active infections | ‘So we prescribe antibiotics where we are convinced or we are sure … that the conditions is mainly as a result of microbial contamination’. P1 |
‘Sometimes you would give amoxicillin if the patient starts having very bad pain’. P5 | |
‘Well in this hospital, periodontitis is one of the common, common conditions for which antibiotics are written for in the dental unit’. P2 | |
1.1.2 Prophylactic use to prevent infections | ‘So most of the antibiotics we give are for prophylaxis against post-extraction complications and infection’. P3 |
‘If you have a patient who has had endocarditis or somebody with heart valve or something, you have to give prophylactic antibiotics at least 30 min before you do any procedure that’s going to involve bleeding. So, like for such patients, even to do scaling and polishing, you would give antibiotics … to make sure that we don’t have any bacteria into the bloodstream’. P5 | |
1.2.1 Access to antibiotics—availability and affordability | ‘… if it’s available within the facility—that will also be a factor that would contribute to my prescribing drugs. Because if you would write an antibiotic and the patient would have to go round looking for it and they can’t find it, then what is the use? So, you write the readily available ones’. P4 |
‘So our basic drugs are really available … unless we have Ludwig’s angina and stuff like that, our basics is penicillin and metronidazole’. P5 | |
‘… not all of them come here being insured under National Health Insurance Scheme (NHIS). If they are insured and they can get it under NHIS it’s good and I’ll prescribe that’. P2 | |
‘If the patient can seem to afford, we would write the more expensive ones, which we think will be effective. But if they, they can’t afford, we write the ones that they can afford for them and hope that it does the same work’. P4 | |
1.2.2 Diagnostic testing | ‘Where there is a need be for you know you’ve diagnosed an infection then I may give an antibiotic while waiting for my X-ray or whilst waiting for my culture and sensitivity results’. P2 |
‘The only time we go beyond those guidelines is if we’ve done like I said, lab culture or analysis …’. P1 | |
1.2.3 Infection prevention and control | ‘Ideal situation is the mouth should be clean and the instruments are all brand new that you will use them, and sterilized’. P2 |
‘In our setting, we prescribe antibiotics a lot and that’s quite unfortunate because we do not use new instruments for every patient. We have to autoclave and sterilize them. Elsewhere they have the luxury of discarding the instruments and using a new set of instruments … we even tag our environment as filthy’. P3 | |
1.3 Influence of colleagues—hierarchies | If my boss is not around, I usually call to inform him before prescribing … describing the condition to him and all those things before prescribing’. P8 |
‘… drugs that your bosses have used before which they found to be very effective might become drugs that can form part of your P drugs’. P4 | |
‘I don’t prescribe antibiotics in the hospital as a pharmacist because we have a dental unit which prescribes. I do recommend or prescribe maybe at home, over the weekends, where most dental facilities are closed, and then I make recommendations for suspected infections which I think will need antibiotic cover, like those with cavities and gum swelling’. P7 | |
‘They come around, do their presentations what not, but very often than not … it’s not like we are not open to new suggestions or new ideas or anything but per … I mean, we also do our own … it’s not just what they tell us, we don’t just take what they tell us at face value’. P7 | |
1.4 Availability of antibiotics without a prescription | ‘Availability per se may not influence whether you prescribe or not [in the hospital setting], but I think the general perception is that they’re accessible, they’re available, and there are so many pharmacies around. People can even walk into pharmacies for antibiotics and they can get it’. P6 |
‘So the more rural you go, the less likely you’re going to have a hospital [and] dental care services [and] the more chemical shops you have … so people are likely to do self-medication … because the distance alone’. P7 | |
1.5 Delays in seeking professional help | ‘Culturally, people are used to taking antibiotics … abusing antibiotics. It’s a cultural problem’. P7 |
‘They go to the drug store first, get antibiotics and will be taking and when they see there is no change, then they come … Usually they stay in the house for a very long time before the come’. P9 ‘In our system it is more of a treat me when I’m sick … So they’re always in at the stage where there is the need to either extract it or do special procedures’. P2 | |
‘They will want you to give them antibiotics. And that also sometimes puts the pressure on you, the prescriber, in order to satisfy the patient’s demands’. P6 | |
1.6 Hygiene concerns | ‘… you can have a wound that is exposed to sand, and debris, gutter water, and whatever … You don’t expect us to attend to that wound and not give antibiotics’. P1 |
‘It influences my decision … if the patient has a poor oral hygiene, the mouth itself is not too good, right for you to do any procedure’. P2 | |
1.7 Medication adherence | ‘Some of the patients you prescribe the medication for them and because they cannot afford, they are not able to buy all or take them’. P3 |
Theme or Subtheme | Quote and Participant Number |
---|---|
2 Knowledge and training about AMR and AMS | ‘They came and trained my bosses some time ago, but I have, I have just read about it’. P8 |
2.1 Consequences of AMR | ‘It’s a problem everywhere. Like, sooner or later we are going to have very serious issues with AMR, cause imagine you’re sick, we’ve identified certain organisms even like we’ve given you some medication but you’re not getting better because these organisms are having a field day … like it will be such a terrible thing and it will probably kill more than half of our population, if care is not taken’. P1 |
‘For antibiotic stewardship, I know is to promote the use of antibiotics and to promote the appropriate use of drugs to prevent resistance. That’s what I know for antibiotic resistance stewardship, to do every possible best to use the right antibiotic to prevent the patient from being resistant to the drug’. P12 | |
2.2 Causes of AMR | ‘… some people refuse to follow the … way they are supposed to take the medicine … The person will take it, let’s say three days, and he’s finding out that he’s feeling better, so there is no need to continue. So they will leave the rest … they don’t complete the full course. So in that case, the person can develop resistance to the antibiotics’. P11 |
‘I think the resistance is a main problem because it seems people are really misusing antibiotics’. P11 | |
‘So resistance can come from both ends. Either because the, the doctor is giving, going beyond the first line, to give third line and fourth line or the doctor is writing subtherapeutic dose so the dosage is lower than what can kill the bacteria or what can stop the activity. Or the patient discontinued the use of the antibiotic midway, before treatment, the period of treatment has elapsed. All these can cause antibiotic resistance’. P4 | |
‘So the problem is that most pharmacies are serving antibiotics without prescriptions’. P3 | |
2.3 Role of prescribers in tackling AMR | ‘One thing we tell them is never buy an antibiotic outside if … a doctor hasn’t seen, or a dentist hasn’t prescribed’. P2 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sneddon, J.; Thompson, W.; Kpobi, L.N.A.; Ade, D.A.; Sefah, I.A.; Afriyie, D.; Goldthorpe, J.; Turner, R.; Nawaz, S.; Wilson, S.; et al. Exploring the Use of Antibiotics for Dental Patients in a Middle-Income Country: Interviews with Clinicians in Two Ghanaian Hospitals. Antibiotics 2022, 11, 1081. https://doi.org/10.3390/antibiotics11081081
Sneddon J, Thompson W, Kpobi LNA, Ade DA, Sefah IA, Afriyie D, Goldthorpe J, Turner R, Nawaz S, Wilson S, et al. Exploring the Use of Antibiotics for Dental Patients in a Middle-Income Country: Interviews with Clinicians in Two Ghanaian Hospitals. Antibiotics. 2022; 11(8):1081. https://doi.org/10.3390/antibiotics11081081
Chicago/Turabian StyleSneddon, Jacqueline, Wendy Thompson, Lily N. A. Kpobi, Diana Abena Ade, Israel Abebrese Sefah, Daniel Afriyie, Joanna Goldthorpe, Rebecca Turner, Saher Nawaz, Shona Wilson, and et al. 2022. "Exploring the Use of Antibiotics for Dental Patients in a Middle-Income Country: Interviews with Clinicians in Two Ghanaian Hospitals" Antibiotics 11, no. 8: 1081. https://doi.org/10.3390/antibiotics11081081
APA StyleSneddon, J., Thompson, W., Kpobi, L. N. A., Ade, D. A., Sefah, I. A., Afriyie, D., Goldthorpe, J., Turner, R., Nawaz, S., Wilson, S., Hart, J., & Byrne-Davis, L. (2022). Exploring the Use of Antibiotics for Dental Patients in a Middle-Income Country: Interviews with Clinicians in Two Ghanaian Hospitals. Antibiotics, 11(8), 1081. https://doi.org/10.3390/antibiotics11081081